Commission Decision 2007/333/EC of 8 May 2007 allowing Member States to extend provisional authorisations granted for the new active substances benalaxyl-M, fluoxastrobin, prothioconazole, spirodiclofen, spiromesifen and sulfuryl fluoride.
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal statusAdopted EU legal act marked as EEA relevant by the EU but considered by the EEA EFTA States not to be relevant for incorporation into the EEA Agreement. There may be a number of reasons for this: the act may fall outside the scope of the EEA Agreement; it may have expired in the EU; or incorporation may not be required due to the contents or nature of the act. For some of the acts, discussions with the EU on their relevance are still ongoing.
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances